Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004654674 | SCV005146344 | uncertain significance | not specified | 2024-04-04 | criteria provided, single submitter | clinical testing | The p.Q256K variant (also known as c.766C>A), located in coding exon 8 of the NEBL gene, results from a C to A substitution at nucleotide position 766. The glutamine at codon 256 is replaced by lysine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. |